Immunic - 54 Year Dividend History | IMUX
Historical dividend payout and yield for Immunic (IMUX) since 1971. The current TTM dividend payout for Immunic (IMUX) as of January 31, 2025 is $0.00. The current dividend yield for Immunic as of January 31, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.089B |
$0.000B |
|
Immunic Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis and psoriasis. The company's product candidate consists of IMU-838, IMU-935 and IMU-856 which are in clinical stage. Immunic Inc., formerly known as Vital Therapies Inc., is based in San Diego, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
